Table 2.

Multivariable logistic regression models to evaluate DRPH-associated factors.

Variables	PQI-01	PQI-03	PQI-14	PQI-16
	aOR (95% CI)	aOR (95% CI)	aOR (95% CI)	aOR (95% CI)
Male vs. Female	0.93 (0.84–1.04)	0.97 (0.40–0.83)	1.03 (0.94–1.13)	1.05 (0.96–1.15)
Age category
18–34	0.91 (0.73–1.13)	0.86 (0.74–1.00)	0.95 (0.79–1.15)	0.90 (0.74–1.08)
35–44	0.82 (0.65–1.04)	0.96 (0.82–1.12)	0.98 (0.81–1.19)	0.84 (0.69–1.02)
45–54	REF.	REF.	REF.	REF.
55–64	0.72 (0.58–0.89)	0.85 (0.74–0.98)	0.84 (0.70–1.00)	0.98 (0.83–1.16)
65–74	0.75 (0.62–0.92)	0.83 (0.73–0.95)	0.85 (0.72–1.00)	0.93 (0.79–1.09)
>75	0.77 (0.64–0.92)	0.79 (0.69–0.89)	0.82 (0.70–0.96)	0.86 (0.73–1.00)
Charlson Comorbidities
IMA	0.16 (0.07–0.34)	0.24 (0.17–0.33)	0.27 (0.16–0.43)	0.47 (0.34–0.65)
CHF	0.44 (0.33–0.58)	0.24 (0.19–0.30)	0.28 (0.21–0.37)	0.26 (0.20–0.33)
Peripheral Vascular	0.64 (0.43–0.93)	15.51 (14.25–16.88)	0.76 (0.57–1.02)	5.05 (4.50–5.67)
Cerebro-vascular	0.85 (0.70–1.02)	0.46 (0.39–0.53)	0.76 (0.65–0.90)	0.42 (0.34–0.51)
Dementia	1.73 (1.2 –2.35)	0.91 (0.68–1.20)	1.40 (1.06–1.85)	0.52 (0.33–0.82)
COPD	0.35 (0.26–0.46)	0.28 (0.22–0.34)	0.49 (0.40–0.60)	0.56 (0.47–0.68)
Reumatic diseases	0.64 (0.26–1.55)	0.61 (0.33–1.13)	1.56 (0.97–2.50)	0.71 (0.33–1.52)
Peptic Ulcer	0.88 (0.33–2.38)	0.66 (0.32–1.37)	0.40 (0.13–1.27)	0.16 (0.02–1.20)
Hemi-paraplegia	0.94 (0.35–2.54)	0.20 (0.05–0.83)	0.31 (0.07–1.25)	0.19 (0.02–1.40)
Malignacy	0.72 (0.50–1.03)	0.37 (0.26–0.53)	0.83 (0.63–1.10)	0.37 (0.23–0.59)
Liver disease	1.83 (1.48–2.26)	0.91 (0.75–1.10)	3.35 (2.93–3.84)	0.28 (0.18–0.44)
Metastatic	0.63 (0.37–1.09)	0.02 (0.00–0.16)	0.40 (0.23–0.68)	0.10 (0.02–0.42)
AIDS/HIV	-	2.19 (0.66–7.26)	0.80 (0.11–5.90)	-
Renal disease	0.87 (0.71–1.08)	0.83 (0.73–0.96)	0.80 (0.67–0.96)	1.52 (1.35–1.71)

Significant OR were bolded. All models were adjusted for gender, age and CCI.